LTBR and Sjogren syndrome: Since the formation and maintenance of functional HEV in secondary lymphoid organs of mice is regulated by the LTBR axis [6], as well as in TLT in experimental disease models [7,8,23], LTBR is a novel therapeutic target in Sjögren's syndrome.